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Cis and Trans Regulatory Mechanisms Control AP2Mediated B Cell Receptor Endocytosis via Select
Tyrosine-Based Motifs
Kathleen Busman-Sahay1, Lisa Drake1, Anand Sitaram2, Michael Marks2, James R. Drake1*
1 Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America, 2 Departments of Pathology and Laboratory
Medicine and Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

Abstract
Following antigen recognition, B cell receptor (BCR)-mediated endocytosis is the first step of antigen processing and
presentation to CD4+ T cells, a crucial component of the initiation and control of the humoral immune response. Despite
this, the molecular mechanism of BCR internalization is poorly understood. Recently, studies of activated B cell-like diffuse
large B cell lymphoma (ABC DLBCL) have shown that mutations within the BCR subunit CD79b leads to increased BCR
surface expression, suggesting that CD79b may control BCR internalization. Adaptor protein 2 (AP2) is the major mediator of
receptor endocytosis via clathrin-coated pits. The BCR contains five putative AP2-binding YxxØ motifs, including four that
are present within two immunoreceptor tyrosine-based activation motifs (ITAMs). Using a combination of in vitro and in situ
approaches, we establish that the sole mediator of AP2-dependent BCR internalization is the membrane proximal ITAM
YxxØ motif in CD79b, which is a major target of mutation in ABC DLBCL. In addition, we establish that BCR internalization
can be regulated at a minimum of two different levels: regulation of YxxØ AP2 binding in cis by downstream ITAMembedded DCSM and QTAT regulatory elements and regulation in trans by the partner cytoplasmic domain of the CD79
heterodimer. Beyond establishing the basic rules governing BCR internalization, these results illustrate an underappreciated
role for ITAM residues in controlling clathrin-dependent endocytosis and highlight the complex mechanisms that control
the activity of AP2 binding motifs in this receptor system.
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Concomitant with BCR signaling, antigen-BCR (Ag-BCR)
complexes are also internalized, which is the first step in antigen
delivery to MHC class II-containing compartments for conversion
to peptide-MHC class II complexes. However, the mechanism of
BCR internalization is only poorly understood. BCR endocytosis
appears to be primarily driven by clathrin-coated pits (CCP) [8–
10], though a clathrin-independent pathway may be utilized to
a lesser extent [11,12]. While BCR signaling and endocytosis
occur concurrently, the relationship between the two processes is
controversial. This lab and others have shown that the majority of
BCR endocytosis occurs independent of BCR signaling [7,9,10].
However, other studies have suggested that BCR endocytosis
requires signaling [13], specifically for the recruitment of proteins
such as actin [14], Vav and dynamin [15], or possibly to drive
clathrin phosphorylation [16,17]. Thus, while clathrin coated pits
appear to represent the primary pathway for BCR endocytosis, the
mechanism by which Ag-BCR complexes access CCP and how
this is regulated remains unclear.
Clathrin-coated pits are an assembly of clathrin ‘triskelions’,
which are composed of three clathrin heavy chains and three
clathrin light chains [18]. Triskelions assemble into a polyhedral
lattice that stabilizes vesicle formation. However, clathrin does not
directly bind endocytic receptors. Instead, endocytic cargo is

Introduction
B lymphocytes are professional antigen presenting cells that
present peptide–MHC class II complexes to CD4+ T cells to drive
antibody class switching and affinity maturation. Efficient B cell
antigen presentation depends upon initial BCR-mediated antigen
binding and internalization [1–3]. The BCR is composed of an
antigen binding subunit made up of a membrane-bound
immunoglobulin molecule, which is non-covalently associated
with the CD79a/CD79b heterodimer that drives BCR signaling
[4]. Naı̈ve B cells co-express an IgM and IgD BCR. The
cytoplasmic domains of the antigen binding subunit of these BCR
molecules are short (i.e., lysine-valine-lysine, KVK). Therefore,
antigen-induced BCR signaling and endocytosis are mediated
through the cytoplasmic domains of CD79. Antigen binding
results in clustering of plasma membrane BCR molecules, driving
CD79 ITAM tyrosine phosphorylation by Src family kinases such
as Lyn [5], recruitment of Syk [6] and initiation of multiple
downstream signaling pathways. However, cross-linking results in
ITAM phosphorylation of only a small fraction of antigen-engaged
BCR molecules, which are then retained at the cell surface. In
contrast, a large fraction of antigen-BCR complexes remain
unphosphorylated and are rapidly cleared from the cell surface
[7].
PLOS ONE | www.plosone.org
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recognized by adaptor proteins such as AP2 [19], which interact
with the receptor and recruit clathrin triskelions to the forming
CCP [20]. The predominant endocytic clathrin adaptor is AP2,
which interacts with one of two common motifs in the cytoplasmic
domain of a receptor, an acidic dileucine motif conforming to the
consensus E/DxxxLL/I or a YxxØ motif where Ø represents
a bulky, hydrophobic amino acid such as leucine or isoleucine.
Each AP2 complex is composed of two large (a and b), one
medium (m), and one small (s) subunit [21]. Moreover, the solved
crystal structures of AP2 bound to various endocytosis motifs
clearly distinguish the YxxØ binding site on the m subunit [22]
from the dileucine-binding site that is largely located on the s
subunit [23]. However, despite several studies into the mechanism
of BCR internalization, the adaptor that mediates BCR internalization and the precise location of the adaptor-binding site
within the BCR remains unknown.
There are six tyrosines within the cytoplasmic domain of the
CD79 heterodimer, five of which lie within a YxxØ putative AP2
binding motif. Each subunit of the heterodimer possesses an
ITAM with the consensus sequence [D/E]x7[D/E]x2YxxLx7–
10YxxL/I, meaning that each BCR ITAM contains two YxxØ
motifs. The remaining YxxØ motif is present downstream of the
CD79a ITAM. Both CD79a and CD79b could therefore bind
AP2 and mediate BCR internalization. However, the relative
contribution of each CD79 subunit to BCR internalization is
currently unclear.
The cytoplasmic domain of CD79a clearly contains a functional
endocytosis motif, as it can mediate internalization when expressed
in isolation [24,25] or as an artificially constructed homodimer
[24,26]. Moreover, the membrane proximal ITAM tyrosine (i.e.,
Y182) and the downstream non-ITAM tyrosine (i.e., Y204) of
CD79a have been implicated in constitutive [27] and crosslinking-induced [7] BCR endocytosis, respectively. However,
in vivo analysis of BCR internalization clearly demonstrates a role
for the CD79b ITAM tyrosines in both constitutive and inducible
BCR endocytosis [28]. Moreover, while CD79b is not internalization competent as a monomeric construct, artificial pairing of
two CD79b cytoplasmic domains [24,29–31] or generation of
select mutations within CD79b [24] leads to receptor endocytosis
with kinetics remarkably similar to wild-type BCR. Finally, a recent
study of B cell lymphoma suggests a role for the membrane
proximal ITAM tyrosine in CD79b, Y195, in influencing BCR
surface expression levels [32]. Thus, there is currently no
consensus concerning the molecular mechanism of antigeninduced BCR internalization. While some disparities may be
due to variations in the experimental systems, it also suggests that
the mechanism of BCR internalization is significantly more
complex than originally anticipated.
In the current study, we build upon the recent findings in B cell
lymphomas that mutation of a single BCR CD79 tyrosine appears
to block BCR internalization [32], and establish the mechanistic
details of antigen-induced AP2-mediated BCR internalization.
Using multiple in vitro and in situ approaches, we identify the AP2
binding site of the BCR and distinct mechanisms that control BCR
internalization, including regulation in cis and in trans. These results
establish a role for select ITAM tyrosines in cross-linking-induced,
clathrin-dependent BCR endocytosis, resolve some of the apparent
discrepancies on the mechanism of BCR internalization in the
existing literature and establish and highlight the sophisticated
mechanisms that control BCR-mediated antigen internalization.

PLOS ONE | www.plosone.org

Materials and Methods
Ethics Statement
Mice were housed and used in strict accordance to the
guidelines established by the Albany Medical College Institutional
Animal Care and Use Committee. Animal protocols were
reviewed and approved by the Albany Medical College Institutional Animal Care and Use Committee (Protocol #704326).

Cells for Analysis
A20mWT and IIA1.6 cells were grown and used as previously
reported [33,34]. Splenocytes from B10.Br mice (purchased from
Jackson Laboratories and housed in the AMC Animal Resources
Facility) were harvested and used as previously reported [34].

Electron Microscopy
EM analysis of AP2-BCR association within CCP was
performed via a modification of a previously reported approach
[10]. In brief, A20mWT cells or B10.Br-derived splenocytes were
stimulated with rabbit anti-human IgM-btn (309-065-095; Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA, USA) or
mouse anti-mouse IgMb-btn (AF6-78; BD Pharmingen, San Jose,
CA, USA), respectively, plus goat anti-btn-15 nm gold (25253;
Electron Microscopy Services [EMS], Hatfield, PA, USA) for 5
minutes at 37oC, then cooled. The stained cells were then pressed
between alcian blue-coated coverslips and lysine-coated nickel EM
grids (FCF300-Ni-50; EMS) and quickly separated. The plasma
membrane remaining on the copper grids was fixed and stained
with 1% solutions of OsO4, tannic acid and uranyl acetate. AP2
was detected by staining the exposed cytosolic surface of the
membrane using mouse anti-mouse a-adaptin (AP.6; Abcam,
Cambridge, MA, USA) and Protein A-5 nm gold (courtesy of Dr.
Paul Webster). CCP were distinguished by morphology and gold
particles within CCP were enumerated manually on negatives
from images acquired using a JEOL 100CXII STEM microscope.

Plasmid Generation and Mutagenesis
Yeast two-hybrid: The cytoplasmic domain of murine CD79a
or CD79b was PCR amplified and separately inserted into the
multiple cloning site (MCS) of the pGBT9 yeast two-hybrid
plasmid, which contains the Gal4 DNA binding domain and
a tryptophan marker. Murine AP2m was PCR amplified and
inserted into the MCS of the pACT2 plasmid, which contains the
Gal4 activation domain and a leucine marker. GST-CD79: The
cytoplasmic domains of CD79a, CD79b, or portions thereof, were
PCR amplified and separately inserted into the multiple cloning
site downstream of GST and the Factor Xa cleavage sequence in
the pGEX-5x vector (GE Healthcare Life Sciences). MHC class IICD79 chimera: The MHC class II-CD79 constructs were a gift
from Dr. John Cambier and modified to express the immunodominant epitope from hen egg lysozyme (HEL), residues 47–62, and
a poly-glycine linker at the N-terminus of MHC class II b chain.
This was done to prevent association of the class II a/
b heterodimer with invariant chain, which also contains internalization/AP2-binding motifs. The sequence of the HEL
tether in the context of WT MHC class II and the cytoplasmic
deletion version of the MHC class II were previously reported
[33]. Site directed mutagenesis of the GST-CD79 and MHC class
II-CD79 constructs was performed with the Stratagene QuickChange kit (Agilent Technologies, Santa Clara, CA, USA)
according to the manufacturer’s instructions.

2

January 2013 | Volume 8 | Issue 1 | e54938

AP2-Mediated BCR Endocytosis via YxxØ Motifs

Yeast Two-hybrid

Flow Cytometry

The Saccharomyces cerevisiae strain HF7c (Clontech, Mountain
View, CA, USA) was maintained on complete YPD plates. Cotransformation with pGBT9-CD79 and pACT2-AP2m plasmids
was performed by a modification of the lithium acetate procedure
as described in the Yeast Protocols Handbook from Clontech.
HF7c transformants were selected by spreading on plates lacking
leucine and tryptophan. For colony growth assays, HF7c
transformants were pooled and spotted once or in 5-fold serial
dilutions on plates lacking leucine, tryptophan, and histidine, and
allowed to grow at 30uC for 3–5 days.

Internalization was monitored as previously reported [33].
Briefly, chimeric surface MHC class II-CD79 molecules of
transiently transfected cells were tagged with 10-3.6-btn, the cells
incubated at 37uC for the indicated time, and then noninternalized 10-3.6-btn detected with SA-PE. Reported is the
decrease in MFI of SA-PE staining normalized to time 0.

Statistics
Student’s t test was used to measure statistical significance using
Microsoft Excel 2008 for Mac v12.3.3. Statistical significance is
designated as * p#0.05, ** p#0.01, and *** p#0.001.

AP2 Binding Assay
Results

Biotinylated AP2m subunit was generated using the TnT
Transcription/Translation System combined with the Transcend
Biotinylated tRNA (Promega, Madison, WI, USA). E. coli BL21
(Invitrogen, Grand Island, NY, USA) expressing the GST-fusion
proteins were grown and induced with IPTG according to the
manufacturer’s protocol. The bacteria were lysed by sonication in
a buffer containing 0.5% NP-40, 20mM Tris pH 8.0, 100mM
NaCl and 1mM EDTA. GST-fusion proteins were bound to
glutathione beads, washed and incubated with biotinylated AP2m
(AP2m-btn) for 30 minutes. Following washing, the beads were
boiled in reducing SDS-PAGE sample buffer and the eluted
proteins run on SDS-PAGE and transferred to nitrocellulose
membranes. Ponceau S was used to detect total GST protein
loading and AP2m-btn was detected by western blot with
streptavidin-HRP and ECL (Pierce, Thermo Scientific, Rockford,
IL, USA). For the competitive inhibition assay, peptides were
synthesized by Anaspec (Fremont, CA, USA) and, following the
protocol of [35], resuspended to 1 mM in 0.05% Triton-X-100,
50 mM HEPES (pH 7.3), 10% glycerol, 100 mM KCl, 2 mM
MgCl2, 0.1 mM CaCl2 at pH 7.3. The peptides were mixed with
AP2m-btn for 30 minutes and this mixture was then added to the
washed glutathione-immobilized GST-fusion complex for 30
minutes, followed by the remainder of the basic protocol outlined
above.

CD79b Y195 Drives BCR Internalization
The cytoplasmic domains of the IgM and IgD BCR expressed
by naı̈ve B cells consist of four polypeptide chains; two
immunoglobulin heavy chains (which have short cytoplasmic
domains of the sequence KVK) and those of CD79a and CD79b
(which are ,61 and 48 amino acids in length, respectively;
Figure 1A). The cytoplasmic domains of CD79a and CD79b
contain the two BCR ITAMs that include four of the receptor’s
five YxxØ putative endocytosis motifs.
A recent publication reported that activated B cell-like diffuse
large B cell lymphomas (ABC DLBCL) exhibit increased BCR
surface expression, suggesting a defect in constitutive (and possibly
antigen-driven) BCR internalization. The same publication also
reported that a large portion of ABC DLBCL patients have a point
mutation in the membrane proximal ITAM tyrosine of CD79b
(CD79b Y195, which is part of a YxxØ putative endocytosis motif)
but not of the corresponding membrane-proximal ITAM tyrosine
of CD79a. To determine if there is a link between CD79b Y195
and antigen-driven BCR internalization, the impact of mutating
each CD79 membrane proximal ITAM tyrosine (i.e. CD79a Y182
or CD79b Y195) on cross-linking-induced BCR internalization
was directly tested. We used a model system in which the
cytoplasmic domains of CD79a and CD79b are grafted onto the
extracellular and transmembrane domains of an MHC class II
molecule (Figures 1B and 1C and Figure S1). Here, it should be
noted that class II molecules form only a/b heterodimers. Thus,
homodimeric reporter molecules bearing either two CD79a or two
CD79b cytoplasmic domains will not form under these conditions.
Consistent with the notion that the membrane-proximal ITAM
tyrosine of CD79b might drive BCR internalization, mutation of
CD79b Y195 to either glutamic acid (E, a mutation very similar to
the tyrosine to aspartic acid [D] mutation found in multiple ABC
DLBCLs) or to alanine (A, a more conservative substitution)
completely blocks CD79-driven internalization. Conversely, mutation of the homologous tyrosine in CD79a (i.e., Y182) to
glutamic acid has no effect on BCR internalization. Moreover,
individual mutation of any of the other receptor YxxØ tyrosine
residues to glutamic acid also has no impact on receptor
internalization. When combined with the reported increase in
BCR surface expression in ABC DLBCLs bearing similar point
mutations, these results suggest that CD79b Y195 is a critical
element of the sole active endocytosis motif of the BCR, whereas
CD79a Y182 plays little direct role in the endocytosis of the
CD79a/b heterodimer.

Confocal Microscopy and Image Analysis
IIA1.6 cells, an FcR– derivative of the A20 murine B cell
lymphoma line, were transiently transfected via electroporation
with 10 mg of each of the isolated MHC class II–CD79a and CD79b chain constructs, or mutants thereof. After 20–24 hours,
the cells were collected, washed, and incubated with mouse antimouse I-Ak–Alexa Fluor 488 (10-3.6; BioLegend, San Diego, CA,
USA) for 15 minutes at 37oC. The cells were cooled on ice (and
remained chilled for the remainder of the staining protocol),
washed and stained with anti-mouse IgG2a-Alexa Fluor 594
(Invitrogen), which will stain both primary antibody on the cell
surface and the endogenous BCR. The cells were adhered to
Alcian Blue-coated coverslips, fixed and mounted onto microscope
slides with Fluoro-gel mounting media (EMS). Images are Z stacks
of 1.5 mm slices obtained on an Olympus Fluoview (Center Valley,
PA, USA) FV1000 with a 60x N.A. 1.23 water immersion lens at
room temperature. Individual cells were photographed using an 8x
optical zoom and the presented images depict an internal section
with the highest Alexa Fluor 488-only staining. Three independent
experiments with a total of 100+ cells were imaged, and only
transfected cells containing equal or greater internal staining
compared to external staining were marked as containing
internalized receptor.

PLOS ONE | www.plosone.org

AP2 Mediates BCR Internalization
The finding that mutation of the membrane-proximal ITAM
tyrosine of CD79b, which falls within a putative AP2-binding
YxxØ endocytosis motif, blocks all BCR internalization suggests
3
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Figure 1. CD79b Y195 Controls BCR Internalization. Panel A, Amino acid sequences of the cytoplasmic domains of CD79a and CD79b. YxxØ
putative AP2 binding motifs underlined. Panel B, Confocal laser scanning microscopic analysis of the endocytosis of indicated MHC class II-CD79
chimeric proteins. Plasma membrane is yellow (anti-MHC class II-Alexa 488+ post-endocytic labeling of external MHC class II-CD79 with an Alexa 594labeled antibody). Internalized MHC class II-CD79 is green (anti-MHC class II-Alexa 488 only). Panel C, Quantification of MHC class II-CD79 endocytosis.
100+ cells from across 3 independent experiments were scored for internalization. Reported is the percent of cells showing internalized MHC class IICD79 for each construct. Statistical comparisons were made between the construct with both CD79 cytoplasmic domains and cells expressing other
constructs.
doi:10.1371/journal.pone.0054938.g001

that AP2 is the endocytic adaptor protein mediating BCR
internalization. To determine if this is the case, we first used
electron microscopy to determine if ligand-BCR complexes and
the AP2 adaptor colocalize to plasma membrane CCP (Figure 2).
In the A20mWT B cell line that bears a phosphorylcholine-

PLOS ONE | www.plosone.org

specific human IgM BCR, over 80% of CCP that contain
antigen-BCR complexes also stain for AP2. In normal splenic B
cells, the level of BCR–AP2 colocalization in CCP is almost
75%. We also find significant BCR–AP2 colocalization outside
of morphologically-identifiable CCP (Figure 2 insets), suggesting
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was captured on glutathione beads. The ability of biotin-labeled
AP2m (AP2m-btn) to bind these CD79-coated beads was then
determined (Figure 3D). Consistent with the yeast two-hybrid
results, the in vitro AP2 binding assay confirmed the ability of
the cytoplasmic domain of CD79a, but not that of CD79b, to
directly bind AP2.
These results were extended to the in situ condition by grafting
the cytoplasmic domain of either CD79a or CD79b onto an MHC
class II molecule (which does not form a-a or b-b chain
homodimers) and determining the internalization capacity of the
chimeric molecules (Figures 4A and 4B). When tested in isolation,
the cytoplasmic domain of CD79a, but not that of CD79b, is able
to mediate cross-linking-induced receptor internalization. Taken
together with the results presented in Figure 1, which establish that
mutation of CD79b Y195 to either glutamic acid or alanine blocks
BCR internalization, the results presented in Figures 3 and 4
suggest that in the context of the intact CD79 heterodimer the
presence of CD79a is required to ‘‘activate’’ the AP2 binding
properties of CD79b (i.e., that CD79a positively regulates the AP2
binding properties of CD79b in trans). The alternative, more
convoluted, scenario is that endocytosis of the CD79 heterodimer
is driven by AP2 binding to a YxxØ within CD79a and that this
AP2-CD79a interaction is inhibited by mutation of CD79b Y195
to glutamic acid. However, this possibility is ruled out both by the
observation that a more conservative CD79b Y195A mutation
also blocks heterodimer internalization and by the finding that
mutation of any individual CD79a tyrosine to glutamic acid fails to
block endocytosis of the CD79 heterodimer (Figure 1). These
results establish the central role of AP2 in mediating BCR
internalization and also reveal that the endocytic activity of each
CD79 cytoplasmic domain can be controlled in trans by the
presence or absence of the partner cytoplasmic domain. Furthermore, this finding suggests that there is a complex interaction
between the two CD79 cytoplasmic domains that controls the
endocytic activity of the various BCR AP2 binding motifs.

that in B cells, like other cells, receptors such as the BCR may
interact with patches of membrane-associated AP2 and stabilize
them, allowing subsequent clathrin recruitment and maturation
into a CCP. Together with the finding that mutation of
a putative AP2 binding motif (i.e. CD79b Y195) can completely
block BCR internalization, these results suggest that the YxxØ
motif centered on the membrane proximal ITAM tyrosine of
CD79b binds AP2 to support CCP-mediated BCR internalization.

CD79a/b Pairing Impacts AP2 Binding and Endocytosis
The combined cytoplasmic domains of CD79a and CD79b
possess a total of five YxxØ motifs that may bind AP2
(Figure 3A), yet the membrane proximal ITAM tyrosine of
CD79b (i.e., Y195) appears to be the only motif that drives
AP2-mediated BCR internalization. To confirm the role of the
AP2 adaptor in BCR internalization and more precisely map
the site of AP2 binding, the interaction of AP2 with the
individual cytoplasmic domains of CD79a and CD79b was
investigated. The first step was to use a yeast two-hybrid assay
to determine whether the cytoplasmic domain of CD79a and/or
CD79b interacts directly with the m subunit of AP2 (AP2m, the
AP2 subunit known to bind YxxØ motifs; Figure 3B).
Surprisingly, when tested in isolation the cytoplasmic domain
of CD79b fails to interact with AP2m, whereas the cytoplasmic
domain of CD79a exhibits strong AP2m binding. These results
were unexpected based on the observation that mutation of the
membrane proximal ITAM tyrosine of CD79b blocks BCR
internalization (Figure 1). To confirm the yeast two-hybrid
results and rule out the possibility that the unexpected pattern
of AP2 binding might be due to the nuclear environment where
the interaction took place, an in vitro AP2 binding assay was
used to further address the question. As diagrammed in
Figure 3C, the cytoplasmic domain of either CD79a or
CD79b was linked to GST and the resulting fusion protein

Figure 2. Ultrastructural Colocalization of Ligand-BCR Complexes and AP2 in Clathrin-Coated Pits. A20mWT B cells or primary murine
splenocytes were pulsed with anti-IgM-btn followed by anti-biotin-15 nm gold (arrow heads), incubated 2 minutes at 37u and then plasma
membrane rips were prepared as previously reported [10]. The exposed cytoplasmic face of the plasma membrane was stained with anti-AP2 and
Protein A-5 nm gold (arrows). The percent of BCR-containing CCP that also stained for AP2 is indicated below each image. Inset: AP2 and BCR colocalization within electron dense membrane regions lacking discernable CCP architecture. Shown are representative images from 1 of 3 experiments,
with 1,000+ BCR-bound gold particles or 100+ CCP photographed cumulatively.
doi:10.1371/journal.pone.0054938.g002

PLOS ONE | www.plosone.org
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Figure 3. AP2m Binds to Isolated CD79a but not CD79b. Panel A, Amino acid sequences of CD79a and CD79b cytoplasmic domains. YxxØ
putative AP2 binding motifs underlined. Panel B, AP2m expressed as a Gal4 activation domain fusion protein was assayed for specific interaction with
the cytoplasmic domain of either CD79a or CD79b fused to the Gal4 DNA binding domain. Growth on histidine deficient (His-) plates indicates an
AP2–CD79 interaction. The cytoplasmic domain of TGN38 contains a known AP2 binding YxxØ motif and served as a positive control, while the
cytoplasmic domain of OCA2 contains a dileucine motif (which does not bind AP2m) and served as a negative control. Data are representative of 2
experiments. Panel C, Diagram of the GST-CD79 cytoplasmic domain–AP2m direct binding assay. Panel D, The cytoplasmic domains of CD79a and
CD79b were expressed as GST fusion proteins in BL21 E. coli cells. GST-fusion proteins were captured from cell lysates on glutathione beads and the
resulting matrix was tested for binding to in vitro translated, biotin-labeled AP2m. The AP2 binding motif from TGN38, (SDYQRL)3, and a non-AP2binding derivation containing a tyrosine to glycine substitution, (SDGQRL)3, fused to GST served as positive and negative controls, respectively.
Binding is expressed as a percentage of (SDYQRL)3–AP2 interactions. Data is the mean of 3 independent experiments 6 S.E.M. Statistical comparisons
were measured between SDYQRL and other samples.
doi:10.1371/journal.pone.0054938.g003

CD79a Y182 alone, it appears that the majority of AP2 binding is
driven by the membrane proximal ITAM tyrosine of CD79a. This
analysis was extended to the in situ condition by determining the
impact of a similar set of mutations on the endocytosis of the
MHC class II reporter protein bearing a single isolated CD79a
cytoplasmic domain (Figures 5B and 5C). The findings from this in
situ analysis are fully consistent with those of the in vitro AP2
binding assay and establish that the membrane proximal YxxØ
motif of CD79a is central to its endocytic activity when expressed
in the absence of CD79b.
The results on CD79a-driven endocytosis presented in Figure 5
could either mean that mutation of the membrane proximal YxxØ
motif blocks AP2 binding to that motif or that the mutation acts
via an allosteric mechanism to block AP2 binding to a downstream
YxxØ motif (i.e., Y193 or Y204). To distinguish between these two
possibilities, the in vitro binding of AP2 to GST molecules bearing
21 amino acid fragments of the CD79a cytoplasmic domain
centered on each YxxØ motif was determined (Figure 6A).
Consistent with the notion that AP2 binds directly to the YxxØ
motif centered on the membrane proximal ITAM tyrosine of
CD79a (i.e., Y182), AP2 binding to the GST-21-mer possessing

Flanking Regulatory Elements Control BCR Endocytosis
Motif Activity
Given the surprising finding that CD79a, not CD79b, binds
AP2 and is endocytically active when expressed in isolation
(Figures 3 and 4), the mechanism of ‘‘activation’’ of the isolated
CD79a cytoplasmic domain was investigated. This line of
investigation should also allow us to better understand the
potential mechanism of ‘‘inactivation’’ of the isolated CD79b
cytoplasmic domain as well as regulation of the endocytic activity
of the complete BCR. The first step of this process was to identify
the YxxØ motif driving CD79a-mediated internalization. To this
end, the impact of tyrosine mutation of the three YxxØ motifs in
the cytoplasmic domain of CD79a on in vitro AP2 binding was
determined. Similar to the finding that the membrane-proximal
ITAM tyrosine of CD79b is the sole driver of endocytosis in the
context of the CD79 heterodimer, the membrane proximal ITAM
tyrosine of CD79a (i.e., Y182) is central to the AP2 binding
capacity of the isolated CD79a cytoplasmic domain (Figure 5A).
While combined mutation of CD79a Y182 and Y204 may have
a slightly greater negative impact on AP2 binding than mutation of
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Figure 4. Receptor Endocytosis of Isolated CD79a but not CD79b. Endocytosis of the indicated MHC class II-CD79 fusion proteins was
analyzed (Panel A) and quantitated (Panel B) as in Figure 1. Statistical comparisons were made between the reporter proteins with both CD79
cytoplasmic domains and other reporter proteins.
doi:10.1371/journal.pone.0054938.g004

To further test the ‘‘inherent’’ AP2 binding properties of the two
membrane proximal YxxØ motifs (as well as the other BCR YxxØ
motifs), the AP2 binding capacity of synthetic peptides corresponding to each of the five CD79 YxxØ minimal motifs
(Figure 7A) was tested. This was accomplished by the approach
diagrammed in Figure 7B. First, biotin-labeled AP2m (AP2m-btn)
was mixed with synthetic peptide corresponding to one of the five
BCR-derived YxxØ motifs (the motif was presented in the context
of an 18-mer of the form [xxYxxØ]3). Next, the mixture of AP2btn and BCR-derived peptide was added to beads coated with
a known AP2 binding domain. If the BCR-derived peptide had
bound AP2, it would block binding of AP2 to the beads. The level
of AP2m-btn binding was then determined by SDS-PAGE and
blotted with streptavidin-HRP, and percent inhibition of AP2m-btn
binding to the beads taken as a read-out of BCR-derived peptide
binding to AP2m-btn.
Using this approach, it became readily apparent that each of
the BCR YxxØ motifs has a different inherent capacity to bind
AP2 (Figure 7C and Figure S2). Most notable were the peptides
corresponding to the two membrane proximal YxxØ motifs of
the BCR. The peptide corresponding to the membrane
proximal YxxØ of CD79a fails to bind AP2 when presented
as a minimal peptide, even though it is active in the isolated
CD79a cytoplasmic domain and YxxØ-centered 21-mer
(Figures 5 and 6). This suggests that there may be a positive
regulatory element within +/210 amino acids of the core
tyrosine that is able to act in cis to ‘‘activate’’ the AP2 binding
and endocytic activity of this motif (Figure 6B). Conversely,
peptide corresponding to the membrane proximal YxxØ motif
of CD79b binds AP2 well when presented as a minimal peptide,
which is consistent with the activity of this motif in the CD79
heterodimer [Figure 1]. However, the finding that this motif is
inactive in the isolated CD79b cytoplasmic domain and YxxØcentered 21-mer (Figures 3 and 6) suggests that there is

only the membrane proximal YxxØ motif is almost as strong as
AP2 binding to the complete CD79a cytoplasmic domain.
Moreover, mutation of the YxxØ tyrosine of this 21-mer to either
alanine or glutamic acid significantly decreases AP2 binding (down
to the level of AP2 binding to the intact CD79b cytoplasmic
domain, which fails to mediate endocytosis). In contrast, AP2
binding to the 21-mers centered on the two other CD79a YxxØ
motifs was negligible and essentially unaltered by mutation of the
tyrosine motif. These results establish that, when removed from
the influence of CD79b, the membrane proximal ITAM tyrosine
of CD79a is capable of binding AP2 directly and driving receptor
endocytosis.
The results presented thus far establish that under the right
conditions the YxxØ motifs centered on the membrane proximal
ITAM tyrosines of CD79a and CD79b can mediate AP2 binding
and receptor internalization. Give the striking similarities between
the two motifs (they both have the core sequence of YEGL) it was
puzzling that they are active under such different conditions (i.e.,
the membrane-proximal YxxØ of CD79a is only active in isolation
whereas the homologous YxxØ of CD79b is only active in the
context of the CD79 heterodimer). To further investigate why this
might be the case, the GST-21-mer in vitro AP2 binding assay was
extended to the two YxxØ motifs of CD79b (Figure 6A).
Consistent with the finding that the isolated CD79b cytoplasmic
domain fails to bind AP2 or mediate internalization (Figure 3),
there is little to no appreciable AP2 binding to either of these
constructs. However, when one considers the identity of the core
membrane proximal YxxØ motifs between CD79a and CD79b,
these results suggest that there are likely cis-acting regulatory
elements within +/210 amino acids of the membrane proximal
ITAM tyrosine residues of both cytoplasmic domains that control
AP2 binding and the endocytic activity of these two YxxØ motifs
(Figure 6B).
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Figure 5. The Membrane-Proximal YxxØ Motif of Isolated CD79a Mediates AP2 Binding and Endocytosis. Panel A, The binding of
AP2m-btn to bead-captured GST bearing full length CD79a with the indicated mutations was determined as in Figure 3. Panels B and C, Endocytosis
of the indicated MHC class II-CD79 fusion proteins was analyzed and quantitated as in Figure 1. Statistical comparisons were made between the
reporter protein expressing the wild type CD79a cytoplasmic domains and other reporter proteins.
doi:10.1371/journal.pone.0054938.g005

a negative regulatory element within +/210 amino acids of this
core tyrosine that is able to act in cis to ‘‘inactivate’’ the AP2
binding and endocytic activity of the motif (Figure 6B).
Surprisingly, the two downstream YxxØ motifs of CD79a (i.e.
those centered on Y193 and Y204) also bind AP2 well when
presented in isolation, even though they do not appear to
contribute to BCR endocytosis when presented either as an
isolated CD79a domain or within the context of the CD79
heterodimer (Figures 5 and 1, respectively). In contrast, the
single downstream YxxØ motif of CD79b fails to bind AP2 in
isolation, consistent with the lack of any data suggesting a role
for this motif in BCR internalization. Therefore, there appears
to be regulatory elements within 10 amino acids of the
membrane proximal ITAM tyrosines of each CD79 subunit,
which regulate in cis the AP2 binding and endocytic activity of
the YxxØ motifs centered on these tyrosines.

termined (Figure 8). Consistent with the lack of AP2 binding to 21mers centered on CD79a Y193 or Y204 (Figure 6), deletion of any
or all amino acids C-terminal to methionine 192 failed to decrease
AP2 binding. In contrast, deletion of the DCSM motif (LNLDD)
located just C-terminal to the Y182-centered YxxØ motif
completely ablates AP2 binding, suggesting that DCSM may be
the regulatory element that allows AP2 binding to this YxxØ
motif.
To determine if the lack of AP2 binding to the LNLDD
mutant is due to the removal of an activating effect of the
DCSM motif or simply due to the deletion of four amino acids,
the DCSM and corresponding QTAT region of CD79a and
CD79b were swapped and the in vitro AP2 binding of the
chimeric constructs was tested (Figure 9A). Consistent with the
notion that DCSM acts as an activator to ‘‘turn-on’’ the
upstream YxxØ motif, replacement of the QTAT in CD79b
with DCSM results in a cytoplasmic domain that can now
robustly bind AP2. Moreover, mutation of CD79b Y195 to
either glutamic acid or alanine abolishes AP2 binding,
confirming that the grafted DCSM motif is working in cis to
activate the AP2 binding properties of the membrane proximal
ITAM tyrosine (as opposed to activating a downstream YxxØ
motif). When we switch our attention to CD79a, we find that
replacement of the DCSM of CD79a with QTAT blocks AP2

The ITAM-embedded DCSM and QTAT Motifs Control
AP2 Binding and Endocytosis
To more precisely map the position of the positive regulatory
element that is activating AP2 binding and the endocytic activity
of the membrane proximal YxxØ of CD79a, the in vitro AP2
binding activity of GST fusion proteins bearing C-terminal
deletion mutants of the CD79a cytoplasmic domain was dePLOS ONE | www.plosone.org
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Figure 6. AP2m Directly Binds the YxxØ Motif Centered on the Membrane-Proximal Tyrosine of Isolated CD79a. Panel A, The binding
of AP2m-btn to bead-captured GST bearing 21 amino acid peptides centered on the five CD79 YxxØ motifs was determined as in Figure 3. Binding is
expressed as a percentage of CD79a–AP2 interactions and represents the mean of 3 independent experiments 6 SEM. Statistical comparisons were
measured between CD79a and other samples. Panel B, For both CD79a and CD79b, a positive or negative regulatory motif lies within +/210 amino
acids of the tyrosine residue of the membrane-proximal YxxØ AP2 binding motif. In this example, the motif is arbitrarily depicted as being
downstream of the YxxØ motif.
doi:10.1371/journal.pone.0054938.g006

CD79b Y195 is the sole active BCR endocytosis motif, and that
mutation of this single residue blocks antigen-driven BCR
internalization. Interestingly, another mutation found in a more
limited number of ABC DLBCL patients is deletion of a large
portion of the CD79a cytoplasmic domain [32]. Given our
finding that the presence of the CD79a cytoplasmic domain is
necessary to ‘‘activate’’ the endocytic capacity of CD79b, it is
tempting to speculate that this subset of ABC DLBCL patients
may also have a defect in BCR internalization due to impaired
activation of CD79b-mediated BCR endocytosis in trans.
The AP2 complex is the most highly characterized endocytic
adaptor protein and binding of the YxxØ endocytic motif to the
m subunit of the complex is understood at a molecular level.
While previous identification of the CD79b tyrosines present
within YxxØ endocytosis motifs as critical for BCR internalization suggested a role for AP2 in BCR endocytosis [28,32], this
is the first demonstration that AP2 binds the BCR to mediate
cross-linking-induced receptor internalization. Furthermore, as
previous studies have established both that tyrosine phosphorylation of YxxØ motifs blocks AP2m associations [22] and that
only a small fraction of CD79-based ITAM tyrosines are targets
of phosphorylation during BCR signaling [7], it is not surprising
that BCR signaling and endocytosis are mutually exclusive
functions of the BCR complex [7]. In fact, Clark and colleagues
established that upon antigen binding the minor population of
ITAM phosphorylated BCR molecules remains at the cell
surface, whereas the major population of cross-linked but nonITAM phosphorylated BCR molecules is rapidly internalized
[7]. Consistent with this notion, we have established that

binding, suggesting that in the context of an isolated cytoplasmic domain QTAT acts as a negative regulatory element in cis
to inhibit AP2 binding to upstream YxxØ motifs.
Next, the DCSM/QTAT swap mutants were tested in situ by
grafting the CD79 cytoplasmic domains onto the MHC class II
reporter protein and following internalization of the chimeric
molecules (Figures 9B and 9C). Consistent with the in vitro AP2
binding results, replacement of the DCSM of CD79a with QTAT
results in a block in receptor internalization, whereas replacement
of the QTAT of CD79b with DCSM results in a gain of endocytic
capacity that is based on the membrane proximal ITAM tyrosine
(i.e., CD79b Y195). Therefore, replacement of the QTAT of
CD79b with DCSM from CD79a allows the YxxØ motif centered
on Y195 of the isolated CD79b domain to act as an AP2 binding
site and mediate endocytosis. The results also suggest a potential
mechanism for trans regulation of AP2 binding that will be
discussed below.

Discussion
BCR internalization is the gateway to targeting BCR-bound
antigen to the antigen processing and presentation pathway of
the cell and is central to the ability of B cells to recruit T cell
help. A recent report on ABC DLBCL established a correlation
between increased BCR surface expression (possibly due to
decreased BCR internalization) and a higher-than-expected
frequency of mutation of the membrane proximal ITAM
tyrosine of CD79b [32]. In this report, we extend those studies
by demonstrating that the YxxØ endocytosis motif centered on
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Figure 7. Hierarchical Binding of AP2m to BCR-derived Minimal YxxØ Motifs. Panel A, Amino acid sequences of CD79a and CD79b
cytoplasmic domains. YxxØ putative AP2 binding motifs underlined. Panel B, Diagram of the synthetic peptide–AP2m binding assay. Panel C, 18
amino acid long peptides of the form [xxYxxØ]3 and corresponding to each of the five putative AP2m binding motifs of CD79 were synthesized and
used at a final concentration of 250 mM to block the binding of AP2m-btn to beads coated with GST-TGN38 (GST–[SDYQRL]3). Peptides were also
tested across a decreasing range of concentration (Figure S2). Data is presented as the level of BCR-derived inhibitor peptide binding to AP2m-btn
(percent inhibition of binding to bead-associated target) and is the mean of 3 independent experiments 6 S.E.M. and data were normalized to the
background binding of AP2 to the non-AP2 binding target GST–[SDGQRL]3.
doi:10.1371/journal.pone.0054938.g007

tyrosine phosphorylation of the minimal YxxØ motif corresponding to the membrane proximal ITAM tyrosine of CD79b
blocks the ability of this motif to bind AP2 (Figure S3). Thus,
tyrosine phosphorylation, which is a transient modification, is at
least one molecular mechanism that regulates BCR internalization.

Given the sequence similarity of the membrane proximal
ITAM YxxØ motifs of the BCR, it was surprising that CD79a
and CD79b possess such dramatically different abilities to
interact with AP2 and mediate cross-linking-induced BCR
internalization. It appears that this is because multiple
mechanisms control BCR endocytosis. In addition to inactivation of AP2 binding by signaling-dependent tyrosine phosphor-

Figure 8. C-terminal Deletions Localize the Motif that Drives AP2 Binding to the Membrane Proximal YxxØ Motif of CD79a. Binding
of AP2m-btn to bead-captured GST bearing the indicated C-terminal deletions of CD79a was determined as in Figure 3. Data is the mean of 3
independent experiments 6 S.E.M. and data were normalized to the binding of AP2 to full length CD79a.
doi:10.1371/journal.pone.0054938.g008
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Figure 9. AP2-mediated CD79-driven Endocytosis is Regulated in Cis via ITAM-embedded DCSM and QTAT motifs. Panel A, Binding of
AP2-btn to bead-captured GST bearing the indicated CD79a or CD79b cytoplasmic domains with the indicated mutations was determined as in
Figure 3. Binding is expressed as a percentage of wild type CD79a binding and represents the mean of 3 independent experiments 6 SEM. Statistical
comparisons were measured between the non-mutated CD79a or CD79bDCSM cytoplasmic domains and other samples. Panels B and C, Endocytosis
of the indicated MHC class II-CD79 fusion proteins was analyzed and quantitated as in Figure 1. Statistical comparisons were made between the
reporter protein expressing the wild type CD79a or CD79b cytoplasmic domains and other reporter proteins. Panel D, Diagrammatic representation
of cis and trans regulation of BCR AP2 binding and endocytosis. The open arrows indicate cis regulation by the DCSM and QTAT regulatory motifs.
The closed arrows represent trans regulation of the endocytic activity of each cytoplasmic domain by the presence of the partner cytoplasmic
domain.
doi:10.1371/journal.pone.0054938.g009

Nevertheless, in silico modeling of the CD79b cytoplasmic
domain (Figure S4) predicts a significant tendency toward
a b strand structure in the QTAT region of the molecule.
Interestingly, modeling of CD79b in which QTAT is replaced
by DCSM results in a different predicted structure, with an
a helical stretch in the DCSM region of the molecule. This
suggests that a DCSM-induced change in the local structure/
stability of the cytoplasmic domain may underlie the ability of
DCSM to activate the upstream YxxØ motif. On the flip side,
molecular modeling of the CD79a cytoplasmic domain failed to
reveal a corresponding change in the predicted structure
between the DCSM and QTAT swapped cytoplasmic domains.
However, the protein structure prediction algorithms may not
be sufficiently sensitive to confidently predict any QTATinduced structural changes. Future studies will test this and

ylation, BCR internalization can be regulated in cis by ITAMembedded DCSM and QTAT motifs and in trans by the
presence or absence of the partner cytoplasmic domain
(Figure 9D). The DCSM and QTAT sequences have been
previously implicated in controlling differential signaling by
CD79a and CD79b [36–38]. In this current study and the
related study of Jang et al. [24], replacing the QTAT in CD79b
with DCSM results in ‘‘activation’’ of the upstream membrane
proximal YxxØ motif to allow AP2 binding to the isolated
CD79b cytoplasmic domain and receptor endocytosis. This
result implicates DCSM as an activator of upstream YxxØ
motif activity. Currently, the mechanism by which DCSM
activates AP2 binding is unclear. Analysis of peptides corresponding to the cytoplasmic domains of CD79a and CD79b
suggests that they are both relatively unstructured [39].
PLOS ONE | www.plosone.org
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other potential mechanisms of cis regulation of BCR internalization.
The other mechanism regulating BCR internalization identified in this study is regulation in trans. While the precise
mechanism of trans regulation is currently unclear, consideration
of findings from this study along with those from Jang et al.
[24] provides some clues. First, Jang et al. found that, similar to
this study, the isolated CD79b cytoplasmic domain fails to
mediate receptor internalization. However, they paired two
CD79b cytoplasmic domains (each with its endogenous QTAT
inhibitory motif) and found a restoration of BCR internalization, suggesting that the simple presence of a partner cytoplasmic domain may be sufficient to mediate activation in trans.
Moreover, these results demonstrate that positive regulation in
trans is dominant over QTAT-based negative regulation in cis.
This idea is consistent with a preliminary finding that coexpression of CD79a and CD79b cytoplasmic domains wherein
both possess either a DCSM or QTAT motif (i.e.
CD79a+CD79bDCSM or CD79aQTAT+CD79b) results in receptor internalization via the membrane proximal tyrosine of
CD79b (data not shown). This confirms and extends the Jang
et al. result and means that the DCSM and QTAT motifs
appear not to be the whole story of regulation of BCR
internalization in trans (i.e., trans regulation is not simply the
result of the DCSM CD79a activating the membrane proximal
YxxØ in CD79b, while the QTAT of CD79b inhibits the
membrane proximal YxxØ in CD79a).
Another clue to the mechanism of trans regulation comes from
the findings on the endocytic activity of CD79a in which the
endogenous DCSM is replaced by QTAT. Here, we report that
expression of CD79aQTAT with a very short partner CD79b
cytoplasmic domain (3 amino acids, RHR, Table S1) results in
a receptor that is endocytically inactive (due to the impact of the
QTAT ‘‘inhibitory’’ motif). However, Jang et al. expressed the
CD79aQTAT cytoplasmic domain paired with a slightly longer
partner CD79b cytoplasmic domain (,14 amino acids longer,
ending right before the membrane proximal ITAM tyrosine of
CD79b, Table S1), resulting in an endocytically active receptor.
Thus, the presence of a relatively short ,17 amino acid long
fragment of the CD79b cytoplasmic domain devoid of any YxxØ
motifs or a QTAT regulatory domain is sufficient to act in trans
and overcome the inhibitory effect of having grafted the QTAT
motif into CD79a. Thus, the mechanism of trans regulation of
BCR signaling appears to be completely distinct from that of cis
regulation and likely involves crosstalk between the two cytoplasmic domains (Figure 9D). This general idea is not completely new,
as it has been suggested that there is crosstalk between the two
cytoplasmic domains of the BCR during signaling [29]. However,
this is the first time trans regulation has been shown to control
receptor internalization.
In summary, we have identified the BCR endocytosis motif,
the endocytic adaptor used by the receptor and several
mechanisms by which BCR internalization is regulated. In
addition to blockade of AP2 binding via tyrosine phosphorylation, the ITAM embedded DCSM and QTAT motifs previously
implicated in controlling BCR signaling [36–38] act in cis to
control AP2 binding motif activity. Regulation of BCR internalization also occurs in trans via the presence or absence of
the partner CD79 cytoplasmic domain. These findings suggest
that like BCR signaling, BCR internalization is a highly
regulated process that is precisely tuned to give the appropriate
response to different degrees of receptor cross-linking. Future
studies will provide greater insight into the molecular mechanisms behind this process.
PLOS ONE | www.plosone.org

Supporting Information
Figure S1 Flow Cytometric Analysis of Reporter Construct Internalization. Panel A, Amino acid sequences of the
cytoplasmic domains of CD79a and CD79b. YxxØ putative AP2
binding motifs underlined. Panel B, Flow cytometric analysis of the
endocytosis of the indicated MHC class II-CD79 chimeric protein.
Data is the mean of 3 independent experiments (except for the
CD79b Y206E sample, which is the mean of 2 independent
experiments) 6 S.E.M. Statistical comparisons were made
between the construct with both CD79 cytoplasmic domains and
cells expressing other constructs.
(TIF)
Figure S2 Titration of BCR-derived Inhibitor Peptides
in AP2 Binding Assay. 18 amino acid long peptides of the form
[xxYxxØ]3 and corresponding to each of the three AP2m binding
motifs of CD79 (Figure 7) were used across a range of
concentrations up to 250 mM to block the binding of AP2m-btn
to beads coated with GST-TGN38 (GST–[SDYQRL]3). Data is
the mean of 3 independent experiments 6 S.E.M. and was
normalized to the background binding of AP2 to the non-AP2
binding target GST–[SDGQRL]3.
(TIF)

Tyrosine Phosphorylation Blocks AP2 Binding to BCR-derived Peptides. 18 amino acid long peptides of
the form [xxYxxØ]3 and corresponding to the CD79 YxxØ motifs
centered on CD79b Y195 were synthesized with tyrosine (Y),
phosphotyrosine (pY), glutamic acid (E) or valine (V) in the ‘‘Y’’
position of the YxxØ motif. All were tested for AP2m binding at
250 mM as in Figure 7. Data is the mean of 3 independent
experiments 6 S.E.M. and was normalized to the background
binding of AP2 to the non-AP2 binding target GST–[SDGQRL]3.
(TIF)
Figure S3

Figure S4 Predicted Structure of CD79 Cytoplasmic
Domains. The amino acid sequences of the cytoplasmic domains
of CD79a and CD79b as well as CD79b DCSM (CD79b with
QTAT replaced by DCSM) and CD79a QTAT (CD79a with
DCSM replaced by QTAT) were uploaded to the Phyre2– Protein
Homology/analogY Recognition Engine V 2.0 (http://www.sbg.
bio.ic.ac.uk/phyre2/html/page.cgi?id = index) and analyzed under the ‘‘intensive’’ modeling mode [40]. Shown is the ‘‘Secondary
structure prediction’’ for each of the four sequences. Replacing the
DCSM of CD79a with QTAT from CD79b has very little impact
on the predicted structure of the cytoplasmic domain, as both are
predicted to have a strong a-helical tendency. However, replacing
the QTAT of CD79b with DCSM from CD79a induces the
formation of a short run of predicted a-helical structure
immediately downstream of the membrane-proximal YxxØ. Since
this region of wild type CD79b is predicted to have a strong bstrand tendency, these results suggest that DCSM may have an
effect on domain structure that is favorable for AP2 binding. A
similar predicted secondary structure, with an ‘‘induced’’ short ahelical run in CD79b DCSM was observed when the same
sequences were analyzed with the I-TASSER structure prediction
algorithm (http://zhanglab.ccmb.med.umich.edu/I-TASSER/)
[not shown] [41].
(TIF)
Table S1 Comparison of Cytoplasmic Domains Used to

Test BCR Endocytosis.
(TIF)
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